abstract |
Stabilized pharmaceutical formulations of insulin analogues and/ or insulin derivatives are disclosed. In particular, the application is directed to a pharmaceutical formulation comprising (a), at least one analogue and/or derivative of insulin; and (b). Zn(ll); and (c). optionally protamine; wherein the pharmaceutical formulation is free of glycerol. |